AG-Telmisartan tablet recall in Canada: Product quality issue
In plain language
This recall involves Angita AG-Telmisartan 40 mg and 80 mg tablets sold in Canada. It's being recalled because some tablets may be overweight or underweight, affecting the dosage. Consult your healthcare provider before stopping use and follow the return steps in the official notice.
What to do
- Verify if your product is affected by checking the lot numbers.
- Consult your healthcare provider before discontinuing use.
- Contact the recalling firm if you have questions.
- Report any health product related side effects to Health Canada.
Get alerts for recalls like this
Get email alerts when new recalls affect products in this category.
Affected products
AG-Telmisartan 40 mg tablet
Lot: EG23AGI001, EG23AGI002, EG23AGI003, EG23AGD001, EG23AGD002, EG23AGD003
AG-Telmisartan 80 mg tablet
Lot: EG22AGE002, EG23AGE001, EG23AGE002, EG23AGE004, EG23AGE005, EG23AGJ001, EG23AGJ002, EG23AGJ003
Why this matters
Product quality issue affecting dosage
Do I have this product?
This recall only applies to specific products. Follow the steps below to check.
- 1
Check the product name
Make sure your product name matches one of the affected products listed above.
- 2
Check the lot number
Lot numbers identify specific production batches.
Affected lots: EG22AGE002, EG23AGE001, EG23AGE002, EG23AGE004, EG23AGE005, EG23AGJ001, EG23AGJ002, EG23AGJ003, EG23AGI001, EG23AGI002, EG23AGI003, EG23AGD001, EG23AGD002, EG23AGD003
If your product matches one or more of the details above, it may be affected by this recall.
If your product does not match these details, it is not affected by this recall.
When in doubt, always check the official notice.
Frequently Asked Questions
Why was this product recalled?
Product quality issue affecting dosage
What should consumers do?
Verify if your product is affected by checking the lot numbers. Consult your healthcare provider before discontinuing use. Contact the recalling firm if you have questions. Report any health product related side effects to Health Canada.
Where was the product sold?
This product was sold in Canada. For specific retailers or distribution areas, please check the official recall notice linked on this page.
Is there a health risk?
Yes, there may be a health risk. Product quality issue affecting dosage
When was this product recalled?
This product was recalled on September 9, 2024.
Is the Angita brand affected by this recall?
Yes, Angita products are affected by this recall. This recall involves Angita AG-Telmisartan 40 mg and 80 mg tablets sold in Canada. It's being recalled because some tablets may be overweight or underweight, affecting the dosage. Consult your healthcare provider before stopping use and follow the return steps in the official notice.